PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatocellular carcinoma |
| Symptom | C0155773|portal vein thrombosis |
| Sentences | 26 |
| PubMedID- 23000237 | Radioembolization for hepatocellular carcinoma with portal vein thrombosis: impact of liver function on systemic treatment options at disease progression. |
| PubMedID- 25847227 | Background: the safety and efficacy of yttrium 90 (90 y) therapy for unresectable infiltrative hepatocellular carcinoma (hcc) with portal vein thrombosis (pvt) requires further evaluation. |
| PubMedID- 22330617 | Surgical approach to multifocal hepatocellular carcinoma with portal vein thrombosis and arterioportal shunt leading to portal hypertension and bleeding: a case report. |
| PubMedID- 22689916 | It is a safe and effective treatment prolonging the survival of hepatocellular carcinoma patients with portal vein thrombosis. |
| PubMedID- 22206054 | Atypical enhancement pattern of hepatocellular carcinoma with portal vein thrombosis on multiphasic ct. |
| PubMedID- 22237844 | hepatocellular carcinoma patient with main portal vein thrombosis. |
| PubMedID- 25584161 | Transarterial chemoembolization in unresectable hepatocellular carcinoma with portal vein thrombosis: a perspective on survival. |
| PubMedID- 21190093 | Introduction: portal vein thrombosis is frequently associated with hepatocellular carcinoma (hcc). |
| PubMedID- 21659784 | Long-term outcome of combined interferon-alpha and 5-fluorouracil treatment for advanced hepatocellular carcinoma with major portal vein thrombosis. |
| PubMedID- 26133576 | Is radioembolization ((90)y) better than doxorubicin drug eluting beads (debdox) for hepatocellular carcinoma with portal vein thrombosis. |
| PubMedID- 21076591 | This simplified method demonstrates excellent technical feasibility, an acceptable range of complications, and is hence recommended for the management of advanced hepatocellular carcinoma with portal vein thrombosis. |
| PubMedID- 21443089 | Chemoembolization for unresectable hepatocellular carcinoma in patients with or without portal vein thrombosis. |
| PubMedID- 23914915 | Complete pathological regression of hepatocellular carcinoma with portal vein thrombosis treated with sorafenib. |
| PubMedID- 25088384 | Efficacy of transarterial chemoembolization for hepatocellular carcinoma with portal vein thrombosis: a meta-analysis. |
| PubMedID- 25502254 | Eus-fna of a portal vein thrombosis in a patient with a hidden hepatocellular carcinoma: confirmation technique after contrast-enhanced ultrasound. |
| PubMedID- 26157747 | New perspectives on the management of hepatocellular carcinoma with portal vein thrombosis. |
| PubMedID- 21054520 | Background and aim: we aimed to validate the non-invasive criteria for the characterization of portal vein thrombosis (pvt) in patients with cirrhosis and hepatocellular carcinoma (hcc). |
| PubMedID- 23476792 | Treating lobar hepatocellular carcinoma with ipsilateral portal vein thrombosis with yttrium-90 glass-microsphere radioembolization is safe and efficacious. |
| PubMedID- 23914640 | Conclusion: colour doppler sonognaphy is an effective, non-invasive method for evaluating the presence of portal vein thrombosis associated with hepatocellular carcinoma. |
| PubMedID- 21796552 | We aimed to evaluate the magnetic resonance imaging findings of widespread hepatocellular carcinoma lesions complicated with portal vein thrombosis. |
| PubMedID- 25834310 | Management of hepatocellular carcinoma with portal vein thrombosis. |
| PubMedID- 22563286 | Ct scanning is very helpful for identifying the presence and type of gv, to assess gv outflow direction, such as a gastro-renal shunt, to assess the risk of systemic embolization by evo, to identify the presence of hepatocellular carcinoma with or without portal vein thrombosis, and to evaluate the applicability of salvage treatments, such as tips or brto, in cases of evo failure. |
| PubMedID- 20981227 | Treatment of hepatocellular carcinoma with portal vein thrombosis by sorafenib combined with hepatic arterial infusion chemotherapy. |
| PubMedID- 24740759 | Apparent diffusion coefficient quantification as an early imaging biomarker of response and predictor of survival following yttrium-90 radioembolization for unresectable infiltrative hepatocellular carcinoma with portal vein thrombosis. |
| PubMedID- 21224554 | We herein report a case of advanced hepatocellular carcinoma (hcc) with vp4 portal vein thrombosis (pvtt). |
| PubMedID- 21033233 | The efficacy of combined transarterial chemoembolization and 3-dimensional conformal radiotherapy for hepatocellular carcinoma with main portal vein thrombosis. |
Page: 1